Understanding rare infections post-lung transplantation

References

• van Delden C, Stampf S, Hirsch H, et al. Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study. Clin Infect Dis. 2020;71(7): p. e159-e169
   Web of Science ®Google Scholar
• Yeung JC, Machuca TN, Chaparro C, et al. Lung transplantation for cystic fibrosis. J Heart Lung Transplant. 2020;39(6):p. 553–560.
   Web of Science ®Google Scholar
• Hamad Y, Pilewski J, Morrell M, et al. Outcomes in Lung Transplant Recipients With Mycobacterium abscessus Infection: A 15-Year Experience From a Large Tertiary Care Center. Transplant Proc. 2019;51(6):p. 2035–2042.
   PubMed Web of Science ®Google Scholar
• Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med. 2010;152(12):p. 761–9.
   PubMed Web of Science ®Google Scholar
• Husain S, Camargo JF. Invasive Aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):p. e13544.
   Web of Science ®Google Scholar
• Kumar D, Ferreira VH, Blumberg E, et al. A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients. Clin Infect Dis. 2018;67(9):p. 1322–1329. .
   Web of Science ®Google Scholar
• Pellett Madan R, Hand J. Practice, Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):p. e13518.
   Google Scholar
• Serraino D, Piselli P, Busnach G, et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer. 2007;43(14):p.2117–23.
   Web of Science ®Google Scholar
• Grulich AE, Vajdic CM. The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation. Semin Oncol. 2015;42(2):p.247–57.
   PubMed Web of Science ®Google Scholar
• Lebbe C, Legendre C, Frances C. Kaposi sarcoma in transplantation. Transplant Rev (Orlando). 2008;22(4):p. 252–61.
   PubMedGoogle Scholar
• Tessari G, Naldi  L, Boschiero L,  et al. Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant. 2013;13(1):p. 214–21.
   PubMed Web of Science ®Google Scholar
• Frances C, Marcelin AG, Legendre C, et al. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival. Am J Transplant. 2009;9(11):p. 2580–6.
   PubMed Web of Science ®Google Scholar
• Chiereghin A,  Barozzi P, Petrisli E, et al. Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation. Transplantation. 2017;101(8):p. 1935–1944.
   PubMed Web of Science ®Google Scholar
• Piselli P, Busnach G, Citterio F, et al. Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. Transplant Proc. 2009;41(4):p. 1227–30.
   Web of Science ®Google Scholar
• Cahoon EK, Linet MS, Clarke CA, et al. Risk of Kaposi sarcoma after solid organ transplantation in the United States. Int J Cancer. 2018;143(11):p. 2741–2748.
   PubMed Web of Science ®Google Scholar
• Piselli P, Serraino D, Segoloni GP, et al. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer. 2013;49(2):p. 336–44.
   PubMed Web of Science ®Google Scholar
• Riva G, Luppi M, Barozzi P, et al. How I treat HHV8/KSHV-related diseases in posttransplant patients. Blood. 2012;120(20):p. 4150–9.
   PubMed Web of Science ®Google Scholar
• Marcelin AG, Motol J, Guihot A, et al. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. J Infect Dis. 2007;196(8):p. 1163–6.
   PubMed Web of Science ®Google Scholar
• Barete S, Calvez V, Mouquet C, et al. Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol. 2000;136(12):p. 1452–8.
   PubMedGoogle Scholar
• Penn I. Sarcomas in organ allograft recipients. Transplantation. 1995;60(12):p. 1485–91.
   PubMed Web of Science ®Google Scholar
• Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):p. 1317–23.
   PubMed Web of Science ®Google Scholar
• Corbellino M, Bestetti G, Scalamogna C, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood. 2001;98(12):p. 3473–5.
   PubMed Web of Science ®Google Scholar
• Pria AD, Pinato D, Roe J, et al. Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients. Blood. 2017;129(15):p. 2143–2147.
   PubMed Web of Science ®Google Scholar
• Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant. 2013;32(3):p. 341–6.
   PubMed Web of Science ®Google Scholar
• Ambrocio GPL, Aguado S, Carrillo J, et al. Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series. Transplant Proc. 2019;51(2):p. 376–379.
   PubMed Web of Science ®Google Scholar
• Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):p. 1481–9.
   PubMed Web of Science ®Google Scholar
• Kamar N, Rostaing L, Legrand-Abravanel F, et al. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant. 2013;13(7):p. 1935–6.
   Web of Science ®Google Scholar
• Te H, Doucette K. Viral hepatitis: guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant. 2019;33(9):p. e13514.
   PubMedGoogle Scholar
• Lhomme S, Marion O, Abravanel F, et al. Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections. J Clin Med. 2020;9(2): p. 331.
   Web of Science ®Google Scholar
• Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):p. 811–7.
   PubMed Web of Science ®Google Scholar
• Kamar N, Abravanel F, Behrendt P, et al. Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clin Infect Dis. 2019;71(5):p. 1204-1211.
   Web of Science ®Google Scholar
• Pischke S,  Greer M, Hardtke S, et al. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transpl Infect Dis. 2014;16(2):p. 333–9.
   PubMed Web of Science ®Google Scholar
• van der Meijden E,  Horváth B, Nijland M, et al. Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients. J Infect Dis. 2017;215(7):p. 1080–1084.
   PubMed Web of Science ®Google Scholar
• Wu JH, Nguyen HP, Rady PL, et al. Molecular insight into the viral biology and clinical features of trichodysplasia spinulosa. Br J Dermatol. 2016;174(3):p. 490–8.
   Web of Science ®Google Scholar
• Haycox CL, Kim S, Fleckman P, et al. Trichodysplasia spinulosa–a newly described folliculocentric viral infection in an immunocompromised host. J Investig Dermatol Symp Proc. 1999;4(3):p. 268–71.
   PubMedGoogle Scholar
• Shah PR, Esaa FS, Gupta P, et al. Trichodysplasia spinulosa successfully treated with adapalene 0.1% gel and oral valganciclovir in a renal transplant recipient. JAAD Case Rep. 2020;6(1):p. 23–25.
   Google Scholar
• Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol. 2011;70(2):p. 305–22.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Babel N, Comoli P, et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect. 2014;20(Suppl 7):p. 74–88.
   Google Scholar
• Ramirez-Garcia A, Pellon A, Rementeria A, et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Med Mycol. 2018;56(suppl_1):p. 102–125.
   PubMed Web of Science ®Google Scholar
• Bhaskaran A, Hosseini-Moghaddam SM, Rotstein C, et al. Mold infections in lung transplant recipients. Semin Respir Crit Care Med. 2013;34(3):p.371–9.
   PubMed Web of Science ®Google Scholar
• Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis. 2014;16(4):p.578–87.
   Web of Science ®Google Scholar
• Abela IA, Murer C, Schuurmans MM, et al. A cluster of scedosporiosis in lung transplant candidates and recipients: the Zurich experience and review of the literature. Transpl Infect Dis. 2018;20(1):p. e12792.
   Web of Science ®Google Scholar
• Rammaert B, Puyade M, Cornely OA, et al. Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology. Transpl Infect Dis. 2019;21(5):p. e13141.
   PubMed Web of Science ®Google Scholar
• Abelson D, Glanville AR. Controversies and emerging topics in lung transplantation. Breathe (Sheff). 2018;14(4):p.278–287.
   PubMedGoogle Scholar
• Parize P, Boussaud V, Poinsignon V, et al. Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience. Transpl Infect Dis. 2017;19(5):p. e12738.
   PubMed Web of Science ®Google Scholar
• Musk M, C hambersD, C hinW, et al. Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant. 2006;25(10):p.1268–72.
   PubMed Web of Science ®Google Scholar
• Castiglioni B, Sutton DA, Rinaldi MG, et al. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002;81(5):p. 333–48.
   PubMed Web of Science ®Google Scholar
• Sahi H, Avery RK, Minai OA, et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant. 2007;26(4):p. 350–6.
   Web of Science ®Google Scholar
• Symoens F, KNOOP C, SCHROOYEN M, et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant. 2006;25(5):p. 603–7.
   PubMed Web of Science ®Google Scholar
• Husain S, Munoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40(1):p.89–99.
   Web of Science ®Google Scholar
• Tamm M, Malouf M, Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis. 2001;3(4):p. 189–94.
   Google Scholar
• Tortorano AM, Richardson M, Roilides E, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;20(Suppl 3):p.27–46.
   Google Scholar
• Tintelnot K, Just-Nübling G, Horré R, et al. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol. 2009;47(4):p. 351–8.
   Web of Science ®Google Scholar
• Luijk B, Ekkelenkamp MB, De Jong PA, et al. Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum. Case Rep Infect Dis. 2011;2011:p. 1-4.
   PubMedGoogle Scholar
• Vagefi MR, Kim ET, Alvarado RG, et al. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol. 2005;139(2):p.370–3.
   PubMed Web of Science ®Google Scholar
• Denton EJ, Smibert O, Gooi J, et al. Invasive Scedosporium sternal osteomyelitis following lung transplant: cured. Med Mycol Case Rep. 2016;12(p):14–16.
   PubMedGoogle Scholar
• Sayah DM, Schwartz BS, Kukreja J, et al. Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis. Transpl Infect Dis. 2013;15(2):p. E70–4. .
   PubMed Web of Science ®Google Scholar
• Thomson S, Alibhai K, Winkelaar G, et al. Case report of vertebral osteomyelitis and mycotic abdominal aortic aneurysm caused by Scedosporium apiospermum in a lung transplant patient with cystic fibrosis. Transplant Proc. 2015;47(1):p.204–9.
   PubMed Web of Science ®Google Scholar
• Shoham S, Dominguez EA. Practice, Emerging fungal infections in solid organ transplant recipients: guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):p. e13525.
   PubMed Web of Science ®Google Scholar
• Gilgado F, Serena C, Cano J, et al. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother. 2006;50(12):p.4211–3.
   Web of Science ®Google Scholar
• Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother. 2008;52(5):p. 1743–50.
   PubMed Web of Science ®Google Scholar
• Sheu R, Bricker AO, Sahi H, et al. Pseudallescheria boydii (Scedosporium species) in 3 lung transplant recipients: computed tomography findings and literature review. Journal of Computer Assisted Tomography. 2009;33(2):p.247–52.
   PubMed Web of Science ®Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13(2):p. 236–301.
   PubMed Web of Science ®Google Scholar
• Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive Non- AspergillusMold Infections in Transplant Recipients, United States, 2001–2006. Emerg Infect Dis. 2011;17(10):p. 1855–64.
   Web of Science ®Google Scholar
• Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):p.26–34.
   PubMed Web of Science ®Google Scholar
• Almyroudis NG, Sutton DA, Linden P, et al. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6(10):p. 2365–74.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Sun H-Y, Ribaud P, et al. Mucormycosis in Organ and Stem Cell Transplant Recipients. Clinl Infect Dis. 2012;54(11):p.1–8.
   Web of Science ®Google Scholar
• Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):p. 634–53.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Alexander B, Andes D, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):p.1101–11.
   Web of Science ®Google Scholar
• Singh N, Aguado J, Bonatti H, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200(6):p.1002–11.
   Web of Science ®Google Scholar
• Song Y, Qiao J, Giovanni G, et al. Mucormycosis in renal transplant recipients: review of 174 reported cases. BMC Infect Dis. 2017;17(1):p. 283.
   Google Scholar
• Wand O, Unterman A, Izhakian S, et al. Mucormycosis in lung transplant recipients: A systematic review of the literature and a case series. Clin Transplant. 2020;34(2):p. e13774.
   PubMed Web of Science ®Google Scholar
• Silveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med. 2012;120(20):p.211–8.
   Google Scholar
• McGuire FR, Grinnan DC, Robbins M. Mucormycosis of the bronchial anastomosis: a case of successful medical treatment and historic review. J Heart Lung Transplant. 2007;26(8):p.857–61.
   PubMed Web of Science ®Google Scholar
• Reis FPD, Campos SV, Aiello VD, et al. Gastrointestinal mucormycosis post lung transplantation. Braz J Infect Dis. 2019;23(5):p.368–370.
   Web of Science ®Google Scholar
• Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20(Suppl 6):p.74–81.
   PubMedGoogle Scholar
• Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016;30(1):p.143–63.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Arikan-Akdagli S, Dannaoui E, et al. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):p.5–26.
   Google Scholar
• Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016;16(7):p. 828–837.
   Web of Science ®Google Scholar
• Reed C, Bryant R, Ibrahim A, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47(3):p.364–71.
   Web of Science ®Google Scholar
• Muhammed M, Anagnostou T, Desalermos A, et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine (Baltimore). 2013;92(6):p. p. 305–16.
   PubMed Web of Science ®Google Scholar
• Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):p.220–9.
   PubMed Web of Science ®Google Scholar
• Carneiro HA, Coleman JJ, Restrepo A, et al. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore). 2011;90(1):p.69–80 .
   PubMed Web of Science ®Google Scholar
• Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest. 1997;112(4):p.1128–30.
   PubMed Web of Science ®Google Scholar
• Guinvarc’h A, Guilbert L, Marmorat-Khuong A, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses. 1998;41(1–2):p.59–61.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Kessler R, Kravanja C, et al. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant. 2004;23(12):p. 1451–4.
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-Demasters BK. Disseminated Fusarium infection with brain abscesses in a lung transplant recipient. Clin Neuropathol. 2009;28(11):p. 417–21.
   PubMedGoogle Scholar
• Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):p. 695–704.
   PubMed Web of Science ®Google Scholar
• McCarty TP, Baddley JW, Walsh TJ, et al. Phaeohyphomycosis in transplant recipients: results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol. 2015;53(5):p. 440–6.
   PubMed Web of Science ®Google Scholar
• Chowdhary A, Meis JF, Guarro J, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect. 2014;20(Suppl 3):p. 47–75.
   Google Scholar
• Forrest GN, Bhalla P, DeBess EE, et al. Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases. Transpl Infect Dis. 2015;17(3):p. 467–76.
   PubMed Web of Science ®Google Scholar
• Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30(1):p. p. 179–206.
   PubMed Web of Science ®Google Scholar
• Camargo JF, Simkins J, Schain DC, et al. A cluster of donor-derived Cryptococcus neoformans infection affecting lung, liver, and kidney transplant recipients: case report and review of literature. Transpl Infect Dis. 2018;20(2):p. e12836. .
   Web of Science ®Google Scholar
• George IA, Santos CAQ, Olsen MA, et al. Epidemiology of Cryptococcosis and Cryptococcal Meningitis in a Large Retrospective Cohort of Patients After Solid Organ Transplantation. Open Forum Infect Dis. 2017;4(1):p. ofx004. .
   PubMed Web of Science ®Google Scholar
• Sohail A, Smibert OC, Snell G, et al. Cryptococcal infection in lung transplant recipients: A 5-year retrospective review at an Australian transplant center. Transpl Infect Dis. 2018;20(6):p. e12976. .
   PubMed Web of Science ®Google Scholar
• Baddley JW, Forrest GN. Cryptococcosis in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):p. e13543.
   PubMedGoogle Scholar
• Perfect JR, Dismukes W, Dromer F, et al. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clinl Infect Dis. 2010;50(3):p. p. 291–322.
   PubMed Web of Science ®Google Scholar
• Singh N, Lortholary O, Alexander BD, et al. An Immune Reconstitution Syndrome-Like Illness Associated withCryptococcus neoformans Infection in Organ Transplant Recipients. Clin Infect Dis. 2005;40(12):p. p. 1756–61. .
   Web of Science ®Google Scholar
• Krutsinger D, Pezzulo A, Blevins AE, et al. Idiopathic hyperammonemia after solid organ transplantation: primarily a lung problem? A single-center experience and systematic review. Clin Transplant. 2017;31(5): p. e12957.
   Web of Science ®Google Scholar
• Seethapathy H, Fenves AZ. Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients. Am J Kidney Dis. 2019;74(3):p. 390–398.
   PubMed Web of Science ®Google Scholar
• Chen C, Bain KB, Iuppa JA, et al. Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience. Transplantation. 2016;100(3):p. 678–84.
   Web of Science ®Google Scholar
• Bharat A, Cunningham SA, Scott Budinger GR, et al. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015;7(284):p. 284re3.
   PubMed Web of Science ®Google Scholar
• Wylam ME, Kennedy CC, Hernandez NM, et al. Fatal hyperammonaemia caused by Mycoplasma hominis. Lancet. 2013;382(9908):p. 1956.
   PubMed Web of Science ®Google Scholar
• Hocker S, Rabinstein AA, Wijdicks EF. Pearls & oy-sters: status epilepticus from hyperammonemia after lung transplant. Neurology. 2011;77(10):p. e54–6.
   PubMed Web of Science ®Google Scholar
• Vecchio M, Koutsokera A, Touilloux B, et al. Bronchial anastomosis dehiscence and stenosis caused by donor-transmitted Mycoplasma hominis infection in a lung transplant recipient: case report and literature review. Transpl Infect Dis. 2020;00:p. e13475.
   PubMedGoogle Scholar
• Lichtenstein GR, Kaiser LR, Tuchman M, et al. Fatal hyperammonemia following orthotopic lung transplantation. Gastroenterology. 1997;112(1):p. 236–40.
   PubMed Web of Science ®Google Scholar
• Lichtenstein GR, Yang YX, Nunes FA, et al. Fatal hyperammonemia after orthotopic lung transplantation. Ann Intern Med. 2000;132(4):p. 283–7.
   Web of Science ®Google Scholar
• Tuchman M,  Lichtenstein GR, Rajagopal BS, et al. Hepatic glutamine synthetase deficiency in fatal hyperammonemia after lung transplantation. Ann Intern Med. 1997;127(6):p. 446–9.
   PubMed Web of Science ®Google Scholar
• Matson KM, Sonetti DA. Successful treatment of Ureaplasma-induced hyperammonemia syndrome post-lung transplant. Transpl Infect Dis. 2019;21(1):p. e13022.
   Web of Science ®Google Scholar
• Samra Z, Rosenberg S, Dan M. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. J Chemother. 2011;23(2):p. 77–9.
   PubMed Web of Science ®Google Scholar
• Clark NM, Reid GE. Practice, Nocardia infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):p. 83–92.
   PubMedGoogle Scholar
• Restrepo A, Clark NM. Infectious Diseases Community of Practice of the American Society of, Nocardia infections in solid organ transplantation: guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transplant. 2019;33(9):p. e13509.
   PubMedGoogle Scholar
• Santos M, Gil-Brusola A, Morales P. Infection by Nocardia in solid organ transplantation: thirty years of experience. Transplant Proc. 2011;43(6):p. 2141–4.
   Web of Science ®Google Scholar
• Husain S, McCurry K, Dauber J, et al. Nocardia infection in lung transplant recipients. J Heart Lung Transplant. 2002;21(3):p. 354–9.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44(10):p. 1307–14.
   Web of Science ®Google Scholar
• Poonyagariyagorn HK, Gershman A, Avery R ,et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis. 2008;10(6):p. 403–8.
   PubMed Web of Science ®Google Scholar
• Alavi Darazam I, Shamaei M, Mobarhan M, et al. Nocardiosis: risk factors, clinical characteristics and outcome. Iran Red Crescent Med J. 2013;15(5):p. 436–9.
   PubMed Web of Science ®Google Scholar
• Coussement J, Lebeaux D, van Delden C, et al. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study. Clin Infect Dis. 2016;63(3):p. 338–45.
   PubMed Web of Science ®Google Scholar
• Bargehr J, Flors L, Leiva-Salinas C, et al. Nocardiosis in solid-organ transplant recipients: spectrum of imaging findings. Clin Radiol. 2013;68(5):p. e266–71.
   PubMed Web of Science ®Google Scholar
• Hemmersbach-Miller M, Catania J, Saullo JL. Updates on Nocardia Skin and Soft Tissue Infections in Solid Organ Transplantation. Curr Infect Dis Rep. 2019;21(8):p. 27.
   PubMed Web of Science ®Google Scholar
• Coussement J, Lebeaux D, El Bizri N, et al. Nocardia polymerase chain reaction (PCR)-based assay performed on bronchoalveolar lavage fluid after lung transplantation: A prospective pilot study. PLoS One. 2019;14(2):p. e0211989.
   Web of Science ®Google Scholar
• Weinstock DM, Brown AE. Rhodococcus equi: an emerging pathogen. Clin Infect Dis. 2002;34(10):p. 1379–85.
   PubMed Web of Science ®Google Scholar
• Lin WV, Kruse RL, Yang K, et al. Diagnosis and management of pulmonary infection due to Rhodococcus equi. Clin Microbiol Infect. 2019;25(3):p. 310–315.
   Web of Science ®Google Scholar
• Yamshchikov AV, Schuetz A, Lyon GM. Rhodococcus equi infection. Lancet Infect Dis. 2010;10(5):p. 350–359.
   PubMed Web of Science ®Google Scholar
• Arya B, Hussian S, Hariharan S. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature. Clin Transplant. 2004;18(6):p. 748–52.
   PubMed Web of Science ®Google Scholar
• Perez MG, Vassilev T, Kemmerly SA. Rhodococcus equi infection in transplant recipients: a case of mistaken identity and review of the literature. Transpl Infect Dis. 2002;4(1):p. 52–6.
   PubMedGoogle Scholar
• Ursales A, Klein JA, Beal SG, et al. Antibiotic failure in a renal transplant patient with Rhodococcus equi infection: an indication for surgical lobectomy. Transpl Infect Dis. 2014;16(6):p. 1019–23.
   PubMed Web of Science ®Google Scholar
• Hayes D Jr., Diaz-Guzman E, Hoopes CW. Rhodococcus equi infection after lung transplantation. Respir Care. 2011;56(10):p. 1605–7.
   PubMed Web of Science ®Google Scholar
• Le Lay G, Martin F, Leroyer C, et al. Rhodococcus equi causing bacteraemia and pneumonia in a pulmonary transplant patient. J Infect. 1996;33(3):p. 239–40.
   PubMed Web of Science ®Google Scholar
• Gerace E, Lo Presti VDM, Biondo C. Cryptosporidium Infection: epidemiology, Pathogenesis, and Differential Diagnosis. Eur J Microbiol Immunol (Bp). 2019;9(4):p. 119–123.
   PubMedGoogle Scholar
• McAteer J, Jernigan S, Mao C, et al. Cryptosporidiosis among solid organ transplant recipient attendees at a summer camp. Pediatr Transplant. 2020;24(1):p. e13649.
   PubMed Web of Science ®Google Scholar
• Mor SM, Tumwine JK, Ndeezi G, et al. Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis. 2010;50(10):p. 1366–72.
   PubMed Web of Science ®Google Scholar
• Bhadauria D, Goel A, Kaul A, et al. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015;17(1):p. 48–55.
   PubMed Web of Science ®Google Scholar
• Arslan H, Inci EK, Azap OK, et al. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis. 2007;9(4):p. 270–5.
   PubMed Web of Science ®Google Scholar
• Bonatti H, Barroso LF, Sawyer RG, et al. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations. Transpl Infect Dis. 2012;14(6):p. 635–48.
   PubMed Web of Science ®Google Scholar
• Shrivastava AK, Kumar S, Smith WA, et al. Revisiting the global problem of cryptosporidiosis and recommendations. Trop Parasitol. 2017;7(1):p. 8–17.
   PubMedGoogle Scholar
• Lanternier F, Amazzough K, Favennec L, et al. Cryptosporidium spp. Infection in Solid Organ Transplantation: the Nationwide “TRANSCRYPTO” Study. Transplantation. 2017;101(4):p. 826–830.
   PubMed Web of Science ®Google Scholar
• La Hoz RM, Morris MI. Practice, Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):p. e13618.
   Web of Science ®Google Scholar
• Camargo LFA, Kamar N, Gotuzzo E, et al. Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation. 2018;102(2S Suppl 2):p. S27–S34.
   Web of Science ®Google Scholar
• Camargo JF, Simkins J, Anjan S, et al. Implementation of a Strongyloides screening strategy in solid organ transplant donors and recipients. Clin Transplant. 2019;33(4):p. e13497.
   Web of Science ®Google Scholar
• Kim JH, Kim DS, Yoon YK, et al. Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis. Transplant Proc. 2016;48(7):p. 2442–2449.
   Web of Science ®Google Scholar
• Abanyie FA, Gray EB, Delli Carpini KW, et al. Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013. Am J Transplant. 2015;15(5):p. 1369–75.
   PubMed Web of Science ®Google Scholar
• Al-Ob aidi M, Hasbun R, Karen J Vigil KJ, et al. Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017. Open Forum Infect Dis. 2019;6:7.
   Web of Science ®Google Scholar
• Balagopal A, Mills L, Shah A, et al. Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. Transpl Infect Dis. 2009;11(2):p. 149–54.
   PubMed Web of Science ®Google Scholar
• Buonfrate D, Requena-Mendez A, Angheben A, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. 2013;13:78.
   PubMed Web of Science ®Google Scholar
• Opota O, Balmpouzis Z, Berutto C, et al. Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis. Transpl Infect Dis. 2016;18(5):p. 801–804.
   PubMed Web of Science ®Google Scholar
• Lamoth F, Chung SJ, Damonti L, et al. Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis. Clin Infect Dis. 2017;64(11):p. 1619–1621.
   PubMed Web of Science ®Google Scholar
• Greub G, Sahli R, Brouille R, tet al. Ten years of R&D and full automation in molecular diagnosis. Future Microbiol. 2016;11(3):p. 403–25.
   PubMed Web of Science ®Google Scholar